Skip Nav Destination
Issues
1 September 2013
-
Cover Image
Cover Image
The tumor microenvironment contains numerous cellular elements, such as cancer-associated fibroblasts (CAF) and activated myofibroblasts that participate in fibrovascular, vascular, and chemo/cytokine support of tumors. Using bone marrow transplant recipient mice harboring CD44 knockout (KO) mesenchymal stem cells (MSC), the precursor population for CAFs and myofibroblasts, Spaeth and colleagues observed the inability of engrafted CD44-KO stromal cells to provide tumor support, to generate vascular support, and importantly, to transition from the benign MSC phenotype to the tumor-supportive aggressive myofibroblast phenotype. The spectrally unmixed image displays smooth muscle actin + CAFs and myofibroblasts (red) from bone marrow derived CD44-KO (green) MSC in the tumor microenvironment. For details, see article by Spaeth and colleagues on page 5347. - PDF Icon PDF LinkTable of Contents
ISSN 0008-5472
EISSN 1538-7445
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Breaking Advances
Reviews
Perspective
Priority Report
Clinical Studies
Microenvironment and Immunology
Molecular and Cellular Pathobiology
PTK6 Activation at the Membrane Regulates Epithelial–Mesenchymal Transition in Prostate Cancer
Yu Zheng; Zebin Wang; Wenjun Bie; Patrick M. Brauer; Bethany E. Perez White; Jing Li; Veronique Nogueira; Pradip Raychaudhuri; Nissim Hay; Debra A. Tonetti; Virgilia Macias; André Kajdacsy-Balla; Angela L. Tyner
HOXB13 Mediates Tamoxifen Resistance and Invasiveness in Human Breast Cancer by Suppressing ERα and Inducing IL-6 Expression
Nilay Shah; Kideok Jin; Leigh-Ann Cruz; Sunju Park; Helen Sadik; Soonweng Cho; Chirayu Pankaj Goswami; Harikrishna Nakshatri; Rajnish Gupta; Howard Y. Chang; Zhe Zhang; Ashley Cimino-Mathews; Leslie Cope; Christopher Umbricht; Saraswati Sukumar
Prevention and Epidemiology
Therapeutics, Targets, and Chemical Biology
A Synthetic Lethality–Based Strategy to Treat Cancers Harboring a Genetic Deficiency in the Chromatin Remodeling Factor BRG1
Takahiro Oike; Hideaki Ogiwara; Yuichi Tominaga; Kentaro Ito; Osamu Ando; Koji Tsuta; Tatsuji Mizukami; Yoko Shimada; Hisanori Isomura; Mayumi Komachi; Koh Furuta; Shun-Ichi Watanabe; Takashi Nakano; Jun Yokota; Takashi Kohno
AC1MMYR2, an Inhibitor of Dicer-Mediated Biogenesis of Oncomir miR-21, Reverses Epithelial–Mesenchymal Transition and Suppresses Tumor Growth and Progression
Zhendong Shi; Junxia Zhang; Xiaomin Qian; Lei Han; Kailiang Zhang; Luyue Chen; Jilong Liu; Yu Ren; Ming Yang; Anling Zhang; Peiyu Pu; Chunsheng Kang
Tumor and Stem Cell Biology
SOX2 Expression Associates with Stem Cell State in Human Ovarian Carcinoma
Petra M. Bareiss; Anna Paczulla; Hui Wang; Rebekka Schairer; Stefan Wiehr; Ursula Kohlhofer; Oliver C. Rothfuss; Anna Fischer; Sven Perner; Annette Staebler; Diethelm Wallwiener; Falko Fend; Tanja Fehm; Bernd Pichler; Lothar Kanz; Leticia Quintanilla-Martinez; Klaus Schulze-Osthoff; Frank Essmann; Claudia Lengerke
MUC1 Is a Potential Target for the Treatment of Acute Myeloid Leukemia Stem Cells
Dina Stroopinsky; Jacalyn Rosenblatt; Keisuke Ito; Heidi Mills; Li Yin; Hasan Rajabi; Baldev Vasir; Turner Kufe; Katarina Luptakova; Jon Arnason; Caterina Nardella; James D. Levine; Robin M. Joyce; Ilene Galinsky; Yoram Reiter; Richard M. Stone; Pier Paolo Pandolfi; Donald Kufe; David Avigan
Corrections
Advertisement